Journal articles
- Research
- Our research
- Research news
- Journal articles
- Research Summit
- Research Excellence Awards
- Research Excellence Awards 2026
- Research Excellence Awards 2025
- Research Excellence Awards 2024
- Research Excellence Awards 2023
- Research Excellence Awards 2022
- Research Excellence Awards 2021
- Research Excellence Awards 2020
- Research Excellence Awards 2019
- Research Excellence Awards 2018
- Research Excellence Awards 2017
- Reporting
- For patients and consumers
- Clinical trials
- Pre-approval planning
- Ethics approval
- Research governance
- Post-approval submissions
- Supporting research
- Contact us
- Our research
Metro North is committed to providing a platform to acknowledge and promote research excellence within our health service. Below is a list of research publications from across our hospitals and services.
- Programmable Antimicrobial Nanostructured Surfaces: Opportunities and Hurdles for Clinical Translation 30 August 2026Surfaces with programmable nanostructures represent a promising antimicrobial strategy that eradicates bacterial pathogens through physical membrane disruption and/or mechanically induced oxidative stress, independently of conventional antimicrobial resistance mechanisms. Despite their demonstrated and often potent in vitro efficacy, the successful clinical translation of this nanotechnology remains limited. Here, we synthesize the current understanding of how nanoscale […]Thuy P T Nguyen
- The Effects of Continuous Venovenous Hemofiltration on Immunosuppressive Drug concentrations in an Ex-Vivo Model of the critically Ill Adult: (CITRIC) study 29 August 2026CONCLUSIONS: Hydrocortisone and methylprednisolone were cleared by CVVH, while tacrolimus, ciclosporin, and MPA Cl were negligible or absent. Hypoproteinemia and anemia significantly increased drug Cl. These findings provide mechanistic insights and support the need for validation in clinical studies to guide dosing during CKRT.Lucy A Chumas
- Protein Binding Determination of Cefepime, Flucloxacillin, Meropenem, Piperacillin and Tazobactam by Ultrafiltration in Critically Ill Patients: The Choice of Device Matters 29 August 2026CONCLUSION: These findings underscore significant differences in results between ultrafiltration devices, depending on the drug, influenced by NSB. Such factors should be considered when developing methods for determining unbound concentrations of beta-lactam antibiotics.Matthieu Gregoire
- Contemporary epidemiology and real-world management of hepatocellular carcinoma (HCC) in Australia: insights from a prospective Australian National Clinical Quality Registry 28 August 2026CONCLUSIONS: MASLD is emerging as the leading cause of HCC while surveillance uptake remains suboptimal highlighting the importance of both at-risk MASLD case identification and the development of centralised HCC screening for improving the health of Australians. The significant variations in treatment patterns between LTCs and NTCs require further investigation and may provide insights that […]Jonathan Abdelmalak
- Development of a cut-off score for the growth and empowerment measure for Aboriginal and Torres Strait Islander young people (Growth and Empowerment Measure Youth) 28 August 2026No abstractLisa Wittenhagen
- A learner-driven, longitudinal model for high-value care education: early outcomes from the STARS program 28 August 2026CONCLUSION: This evaluation highlights the potential of learner-driven, longitudinal models such as STARS to foster durable engagement with high-value care education and catalyse professional development among medical trainees.Christopher Moriates
- Radiation Dose Reference Levels for Coronary Angiography and Coronary Intervention in Queensland Public Hospitals, Australia 28 August 2026No abstractJames A Crowhurst
- Recent Advances in Therapy for the Neurodegenerative Disorder Ataxia-Telangiectasia 27 August 2026At present, there is no cure for the human genetic disorder ataxia-telangiectasia (A-T), which is managed by supportive care. This disorder arises due to mutations in the ATM (ataxia-telangiectasia mutated) gene and is characterised by a defect in the response to DNA damage, oxidative stress, mitochondrial dysfunction and immune deficiency. The ATM protein is activated […]Sam Nayler
- Detected Delirium Prevalence and Practices in Australia and New Zealand: A Sub-Analysis of the World Delirium Awareness Day Prevalence Study 27 August 2026CONCLUSIONS: In Australia and New Zealand, delirium assessment practices have improved over time. Non-pharmacological strategies are widely used; however, antipsychotic use remains substantial. Workforce constraints, education gaps and system pressures may contribute to variability in delirium care delivery. Addressing these factors, alongside engagement with carers, may support further improvements in care. Ongoing surveillance through repeated […]Shiny Huang
- Diet and physical activity behaviours among people with insomnia symptoms: a cross-sectional survey to understand treatment needs and acceptability 27 August 2026CONCLUSIONS: Findings provide preliminary evidence of an unmet need for interventions to support lifestyle behaviour change among those with insomnia symptoms. While support is acceptable to many, targeted approaches may be needed for subgroups with lower adherence and acceptability.Jacy Hyland
- LTB-TREAT: A validated international prognostic model for time to treatment in low tumour burden follicular lymphoma 27 August 2026Watchful waiting (WW) in low tumour burden follicular lymphoma (LTB FL) defers treatment. There is a need to develop a model to predict time to treatment (TTT). We aimed to develop and externally validate a model for TTT in LTB FL. We conducted a retrospective analysis across eight centres within the Australasian Lymphoma Alliance. Two […]Luani Barge
- ACPSEM guideline: recommendations for a fluoroscopic system quality assurance program 27 August 2026Fluoroscopic systems are increasingly used for complex image-guided procedures across medical disciplines in Australia and New Zealand. The associated radiation exposure risks to patients and staff necessitate robust quality assurance (QA) programs. However, no national guidance has previously existed for a standardised fluoroscopy QA program in the Australia and New Zealand context. To provide evidence-informed […]Mohamed K Badawy
- Safety, efficacy and functional outcomes using a novel, small-diameter defibrillation lead for left bundle branch area pacing: Final results of the LEADR LBBAP clinical trial 26 August 2026CONCLUSIONS: The final study results of the LEADR LBBAP clinical trial demonstrate a continued stable electrical performance, low rate of lumenless defibrillation lead-related major complications, and LOT-CRT therapy benefit when a lumenless defibrillation lead is implanted for LBBAP.Pugazhendhi Vijayaraman
- Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial 26 August 2026Pre-clinical evidence suggests that stereotactic ablative body radiotherapy (SABR) can enhance systemic anti-tumor responses when combined with immune checkpoint inhibition, although optimal fractionation remains uncertain. Here we conducted a phase II multi-center randomized trial (AZTEC trial; ClinicalTrials.gov identifier NCT03464942) to investigate the efficacy and safety of single-fraction (SF: 20 Gy; n = 27) or multi-fraction […]Steven David
- Educational interventions are effective in improving students' ethical and moral outcomes: a systematic review and meta-analysis 26 August 2026Addressing society's greatest challenges, such as climate change, requires us to act as moral agents. If effective, interventions within schools and universities could cultivate ethical and moral attributes in millions of people. This systematic review and meta-analysis, preregistered on the Open Science Framework ( https://osf.io/bdn2u ), synthesizes evidence from 92 randomized controlled trials conducted in […]Geetanjali Basarkod
